BEIJING (Reuters) - China has granted conditional approval to its first self-developed treatment for Alzheimer's disease, a move that may point to revived opportunities in a therapeutic area where ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback